Therapeutic drug management: is it the future of multidrug-resistant tuberculosis treatment?

Shashikant Srivastava, Charles A. Peloquin, Giovanni Sotgiu, Giovanni Battista Migliori
European Respiratory Journal 2013 42: 1449-1453; DOI: 10.1183/09031936.00073213

Article Information

vol. 42 no. 6 1449-1453
DOI 
https://doi.org/10.1183/09031936.00073213
PubMed 
24293417
Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Received April 26, 2013
  • Accepted April 26, 2013
  • Published online November 30, 2013.
Copyright & Usage 
©ERS 2013

Author Information

  1. Shashikant Srivastava1,
  2. Charles A. Peloquin2,
  3. Giovanni Sotgiu3 and
  4. Giovanni Battista Migliori4⇑
  1. 1Dept of Medicine and Office of Global Health, UT Southwestern Medical Center, Dallas, TX
  2. 2College of Pharmacy and Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA
  3. 3Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari–Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari
  4. 4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy
  1. G.B. Migliori, S. Maugeri Foundation, Via Roncaccio 16, Tradate, Varese, Italy. E-mail: giovannibattista.migliori{at}fsm.it
View Full Text

Article usage

Article usage: November 2013 to November 2023

AbstractFullPdf
Nov 201344412
Dec 2013379171280
Jan 20141133655
Feb 2014253942
Mar 2014436332
Apr 2014173625
May 20148409
Jun 2014153914
Jul 201413176
Aug 2014144411
Sep 2014142517
Oct 2014142415
Nov 2014174918
Dec 201412218
Jan 20153167
Feb 2015112010
Mar 2015141310
Apr 201514128
May 201511237
Jun 201592411
Jul 2015111912
Aug 201512175
Sep 2015101712
Oct 201564621
Nov 20156185
Dec 201510185
Jan 201682422
Feb 2016151311
Mar 2016112819
Apr 201614304
May 201610296
Jun 201617338
Jul 2016152815
Aug 2016143015
Sep 2016232715
Oct 2016296915
Nov 2016245514
Dec 2016193111
Jan 201753730
Feb 201744417
Mar 20179398
Apr 2017153119
May 2017243215
Jun 2017153211
Jul 201720368
Aug 201717306
Sep 201710296
Oct 2017163713
Nov 201712417
Dec 201713293
Jan 201813262
Feb 2018142910
Mar 201815308
Apr 20187389
May 201812446
Jun 201815547
Jul 201817336
Aug 201813233
Sep 201812272
Oct 201814577
Nov 201822444
Dec 2018213510
Jan 201919489
Feb 2019155013
Mar 201911436
Apr 201918428
May 201913367
Jun 201919333
Jul 2019174811
Aug 201913848
Sep 2019181958
Oct 2019143912
Nov 2019214016
Dec 20193199
Jan 202018277
Feb 2020283016
Mar 2020410613
Apr 20201379
May 202063917
Jun 20202229
Jul 20205144
Aug 20200176
Sep 20208289
Oct 20208317
Nov 20203228
Dec 20207369
Jan 20212256
Feb 202142114
Mar 2021101711
Apr 202185519
May 202183610
Jun 20212408
Jul 202152310
Aug 20216549
Sep 202132711
Oct 202172445
Nov 202122921
Dec 20210234
Jan 202243711
Feb 20226269
Mar 20227149
Apr 20222298
May 202212913
Jun 20221349
Jul 202221410
Aug 20220266
Sep 202233113
Oct 20222325
Nov 20225197
Dec 20223185
Jan 20230209
Feb 20232106
Mar 20232264
Apr 202323319
May 202342721
Jun 20231184
Jul 202312112
Aug 20231128
Sep 20230139
Oct 20231179
Nov 20231307

Altmetrics

Back to top
View this article with LENS
Email
Print
Citation Tools

Therapeutic drug management: is it the future of multidrug-resistant tuberculosis treatment?
Shashikant Srivastava, Charles A. Peloquin, Giovanni Sotgiu, Giovanni Battista Migliori
European Respiratory Journal Dec 2013, 42 (6) 1449-1453; DOI: 10.1183/09031936.00073213
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

Subjects